Extended CE Mark brings new treatment option to patients in the United Kingdom, Germany and Switzerland

Oraya Therapeutics announced today that the Oraya IRay® Radiotherapy system has received a CE Mark extension for the treatment of choroidal metastases, a cancer in the eye, originating most commonly from primary sites in the breast or lung.



from The Medical News http://ift.tt/1ElAds0